|
Symbol
|
RMALXV | RMADXV | KYCYDU | KYCUDU | RMAZKV | OJSRCH | RMA23V | KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | RMA7AV | AAHKTQ | OMFRCH | OMHRCH | OKKRCH | RMAPGV | RMAMKV | AAGOTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
Nestlé S.A. / Novartis Sandoz Basket / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Novartis AG / Straumann Hldg. AG / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Kühne & Nagel Intl. AG / Lonza Group N / UBS Group AG | ABB / Sonova Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Givaudan / UBS Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / UBS Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
22.06.2026 | 19.04.2027 | 05.06.2026 | 05.06.2026 | 08.06.2026 | 14.06.2027 | 21.12.2026 | 29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 06.07.2026 | 08.07.2026 | 08.07.2026 | 08.07.2026 | 24.06.2026 | 13.07.2026 | 13.07.2026 | 12.01.2027 |
| Bid | - | 100.00 | 98.25 | - | - | 98.64 | - | 94.80 | 58.50 | 98.42 | 95.70 | 56.70 | - | 101.02 | 100.28 | 99.23 | 84.28 | 99.40 | 101.50 | 100.40 |
| Ask | - | 101.00 | 99.25 | - | - | 99.44 | - | 95.80 | 59.50 | - | 96.70 | 57.70 | - | - | - | 100.03 | - | 100.60 | 102.50 | 101.21 |